How AI and Automation are Accelerating the Blood Grouping Reagents Market
Artificial intelligence and automation are revolutionizing the Blood Grouping Reagents Market. AI-powered blood typing systems enhance accuracy, reduce human error, and improve turnaround times, particularly in high-volume hospitals and blood banks.
Automation also streamlines workflow management, allowing labs to handle larger volumes efficiently. These technological integrations are boosting demand and expanding adoption across regions.
Market Outlook: The global market, worth USD 1.2 billion in 2024, is expected to reach USD 2.5 billion by 2034, at a 7.1% CAGR.
2 Views
